Brian T. Crum - 28 Feb 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, General Counsel & Secr.
Signature
/s/ Brian T. Crum
Issuer symbol
LXRX
Transactions as of
28 Feb 2025
Net transactions value
-$30,567
Form type
4
Filing time
03 Mar 2025, 16:28:42 UTC
Previous filing
18 Feb 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +26,097 +15% 203,594 28 Feb 2025 Direct F1
transaction LXRX Common Stock Options Exercise +33,456 +16% 237,050 28 Feb 2025 Direct F1
transaction LXRX Common Stock Options Exercise +69,387 +29% 306,437 28 Feb 2025 Direct F1
transaction LXRX Common Stock Tax liability $30,567 -45,622 -15% $0.6700 260,815 28 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -26,097 -100% 0 28 Feb 2025 Common Stock 26,097 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -33,456 -50% 33,457 28 Feb 2025 Common Stock 33,456 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -69,387 -33% 138,773 28 Feb 2025 Common Stock 69,387 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.